Novel Panel of Breast Cancer Biomarkers - Licensing Opportunity for Dublin City University - August 2017 front page preview

Novel Panel of Breast Cancer Biomarkers - Licensing Opportunity for Dublin City University - August 2017

We have identified a panel of serum biomarkers which when assayed along with CA15-3 can detect breast cancer in 90- 95% of cases examined. This is a major improvement over the existing CA 15-3 tests that are commercia...

pdf 212.7KB

Enduragel - a Novel Therapeutic Filling Material for Treatment of Cerebral Aneurysms - Licensing Opportuity for Dublin City University - August 2017 front page preview

Enduragel - a Novel Therapeutic Filling Material for Treatment of Cerebral Aneurysms - Licensing Opportuity for Dublin City University - August 2017

Enduragel is a minimally invasive injectable hydrogel for the treatment of brain aneurysms and other vascular problems such as Arteriovenous Malformations (AVMs) and dural fistulas. It can be injected through micro-cathe...

pdf 205.7KB

Advancing the development of a novel compound for the treatment of inflammatory disease - Licensing Opportunity for Dublin City University - August 2017 front page preview

Advancing the development of a novel compound for the treatment of inflammatory disease - Licensing Opportunity for Dublin City University - August 2017

DCU and UCD have jointly identified a compound purified from a marine species that exerts potent anti-inflammatory activity. The mechanism of action has been elucidated and the team have shown that the intracellular targ...

pdf 287KB

ChemoGel - A thermoresponsive hydrogel for interventional oncology applications   Licensing Opportunity from RCSI June 2017 front page preview

ChemoGel - A thermoresponsive hydrogel for interventional oncology applications Licensing Opportunity from RCSI June 2017

Thermoresponsive hydrogels have attracted significant attention for drug delivery due to their ability to phase-transition from an injectable liquid at room temperatures to a solid gel at physiological temperatures. Howe...

pdf 507.4KB

PanaColl- A collagen-based scaffold for the delivery of antibiotics and enhancement of tissue regeneration Licensing Opportunity for RCSI June 2017 front page preview

PanaColl- A collagen-based scaffold for the delivery of antibiotics and enhancement of tissue regeneration Licensing Opportunity for RCSI June 2017

Osteomyelitis (OM) is an infection of bone caused by bacteria such as Staphylococcus Aureus (S. Aureus). The current gold standard treatment for chronic OM is debridement of the infected bone followed by administration o...

pdf 462.2KB